CLINICAL_TRIALS
ClinicalTrials.gov record update
Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial (STEPS Trial)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06668389
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:47.112841+00:00
- Published At
- 2025-05-20T00:00:00+00:00
- Record Updated At
- 2025-05-20
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Congenital Heart Disease", "Repaired Tetralogy of Fallot (rTOF)", "Pulmonary Regurgitation", "Sodium-glucose Cotransporter 2 (SGLT2) Inhibitor", "Dapagliflozin (Forxiga)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-05-20"- protocolSection.identificationModule.nctId
"NCT06668389"- protocolSection.identificationModule.officialTitle
"Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial (STEPS Trial)"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.